Top compounds associated with response to ARL16


Feature Type Standardized
Nominal ANOVA
mRNA shikonin GDSC1000 pan-cancer AAC 0.088 0.01
mRNA PI-103 GDSC1000 pan-cancer AAC 0.078 0.01
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.09 0.01
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.087 0.02
mRNA VX-680 CTRPv2 pan-cancer AAC 0.27 0.02
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.087 0.02
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.079 0.02
mRNA BRD-K66532283 CTRPv2 pan-cancer AAC 0.082 0.02
mRNA BEC CTRPv2 pan-cancer AAC 0.19 0.02
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.076 0.02
Download CSV